Effect of natural estrogens on the cardiovascular system;Oestrogenes naturels et systeme cardio-vasculaire

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 25, Issue 3, 1996, Pages 233-237

  Bader, A ^a,c   Sacrez, J ^a   Langer, B ^b   Sacrez, A ^b  

^a Serv de Gynecol et Obstet 1   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c NONE   (France)

Author keywords

Cardiovascular events; Hormone substitution; Menopause

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; ESTROGEN; NITRIC OXIDE SYNTHASE; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN SYNTHASE; NITRIC OXIDE;

ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; ESTROGEN ACTIVITY; ESTROGEN THERAPY; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; THROMBOGENESIS; THROMBOSIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; BIOSYNTHESIS; BLOOD FLOW VELOCITY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; DRUG EFFECT; GENE EXPRESSION REGULATION; PHYSIOLOGY; REVIEW; VASCULAR RESISTANCE;

BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; GENE EXPRESSION REGULATION; HUMANS; NITRIC OXIDE; VASCULAR RESISTANCE;

EID: 0030015624     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985;^/J:1038-43.
2. Grand A. Le Risque cardiovasculaire après la pénopause. Ann Cardiol Angéiol 1992;4/:151-61.
3. Stampfer MJ, Wille WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1995;J/J:1044-9.
4. Henderson BE, Paganini-Hill A, Ross RK. Esrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988;/59:312-7.
5. Bush TL. Long-term effect of estrogen use on cardiovascular death in wome : results from the lipid research clinics (LCR). Follow-up Study (Abstract). Circulation, 1991;S3:728.
6. Hernandez-Avila M, Walker AM, Jick H. Use of replacement estrogens and the risk of myocardial infarction. Epidemiology, 1990;/:128-33.
7. Wolf PH, Madams JH, Finucane FF, Higgins M, Kleinman JC. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones : evidence from a national cohort. Am J Obstet Gynecol 1991;/64:489-94.
8. Stampfer MJ, Colditz GA, Willet WC, Manson JE, Rosner B, Speizer FE et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Eng J Med 1991;32J:756-62.
9. De Lignières. Les strogènes. Facteurs de risque ou de protection cardiovasculaire. Cardiol pratique 1994;2S2:8-9.
10. Silva de Sa MF, Meirelles RS. Vasodilatation effect of estrogen on the human umbilical artery. Gynecol Invest 1977;S:307.
11. Harder DR, Coulson PB. Estrogen receptors and effects of eslrogen on membrane electrical properties of coronary smooth muscle. J Cell Physiol 1979;/00:375-82.
12. Chang WC, Nakao J, Orimo H, Murota SI. Stimulation of prostaglandin cyclooxygenase and prostacycline synthetase activities by estradiol in rat aortic smooth muscle cells. Biochim Biophys Acta 1980;620:472.
13. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;2SS:373-6.
14. Gisclard V, Miller VM, Vanhouette PM. Effect of 17-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther I988;2-:19-22.
15. Williams JK, Adams MR, Klopfenstein S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;S/: 1680-7.
16. Williams JK, Adams MR, Klopfenstein US. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-7.
17. Van Buren G, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992;/6:82833.
18. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1944;S9:52-60.
19. Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, MacLeod KT. Effect of 17-estradioI on contraction, Ca++ current and intracellular free Ca- in guinea pig isolated cardiac myocytes. Br J Pharmacol 1992:706:739-45.
20. Slice SL, Ford SP, Rosazza JP, Van-Orden DE. Role of 4-hydroxylated estradiol in reducing Ca uptake of uterine smooth muscle cells through potential-sensitive channels. Biol Reprod 1987;57:3618.
21. Rhee CY, Spaet TH, Stemerman MB, Lajam F, Shiang HH. Estrogen suppression of surgically induced vascular hperplasia in rabbits. J Lab Clin Med 1977:90:77.
22. Fischer-Dzoga K, Wissler R, Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medical tissue cells induced by hyperlipemic serum. Exp Mold Pathol 1993:39:355.
23. Fahrat MY, Vargas R, Dingaan B, Ramell PW. In vitro effect of estradiol on thymidine uptake in pulmonary vascular smooth muscle cell : role of the endothelium. Br J Pharmacol 1992;/07:679-83.
24. Vargas R, Wroblewska B, Rego A, Hatch J, Rarmvell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993; 709:612-7.
25. Karas RH, Baur W, Tassi L, Mendelsohn ME. Inhibition of vascular smooth muscle cell growth by estrogen. Circulation 1993;SS:325.
26. Young R, Goepfert AR, Goldziener HW. Estrogen replacement therapy is not conductive of venous thromboembolism. Maturitas I99l;A?:189-92.
27. Gaben A-M, Mester J. BALB/C mouse 3T3 fibroblast expressing human estrogen receptor. Effect of estradiol on cell growth. Biochem Biophys Res Commun 1991;/76:1473-8I.
28. Ma ZQ, Sreafico E, Pollio G, Santagati S, Conti E, Cattaneo E et al. Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc Natl Acad Sei USA 1993;90:3740-4.
29. Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978;20/:817.
30. Nakao J, Chang WC, Murota SI, Orimo H. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Atherosclerosis 1981;S:75.
31. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoides. J Clin Invest 1982;62:750.
32. Lin AL, Shain SA. Estrogen-mediated cytoplasmic and nuclear distribution of rate cardiovascular estrogen receptors. Arteriosclerosis 1985:5:668-77.
33. Losordo DW, Kearney M, Kirn EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptorin normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;S9:1501-10.
34. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988:20:889-95.
35. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family : structure and functions. Endocrinol Rev 1990;//:201-20.
36. Beato M. Gene regulation by steroid hormones. Cell 1989:56:335.
37. Gronemeyer H. Control of transcription activation by steroid hormone receptors. FASEB J 1992;6:2524-9.
38. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;S9:1943.